Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway

Nature Medicine

Volumn 7, Issue 7, 2001, Pages 821-826

  Vergnolle, N ^a   Bunnett, N W ^b   Sharkey, K A ^a   Brussee, V ^a   Compton, S J ^a   Grady, E F ^b   Cirino, G ^c   Gerard, N ^d   Basbaum, A I ^b   Andrade Gordon, P ^e   Hollenberg, M D ^a   Wallace, J L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d HARVARD MEDICAL SCHOOL   (United States)

^e R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; NEUROKININ 1 RECEPTOR; PREPROTACHYKININ; PROSTAGLANDIN SYNTHASE; PROTEIN FOS; PROTEINASE ACTIVATED RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE DELETION; HYPERALGESIA; INFLAMMATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORY NERVE; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; GENES, FOS; HYPERALGESIA; INFLAMMATION; MALE; MICE; MICE, KNOCKOUT; PAIN; PROSTAGLANDINS; RATS; RATS, WISTAR; RECEPTOR, PAR-2; RECEPTORS, NEUROKININ-1; RECEPTORS, THROMBIN; SPINAL CORD; SUBSTANCE P;

EID: 0034927070     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/89945     Document Type: Article

References (43)

1. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases
2. Protease-activated receptors: PAR4 and counting: How long is the course?
3. Rat proteinase-activated receptor-2 (PAR2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue
4. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw
5. Protease-activated receptors in inflammation, neuronal signaling and pain
6. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
7. Proteinase-activated receptor 2 (PAR2)-activating peptides: Identification of a receptor distinct from PAR2 that regulates intestinal transport
8. Prostaglandins, aspirin-like drugs and analgesia
9. Interactions of mast cell tryptase with thrombin receptors and PAR2
10. Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord
11. Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1
12. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation
13. Effect of neurokinin A, substance P and calcitonin gene related peptide in peripheral hyperalgesia in the rat paw
14. The non-peptide NK1 receptor antagonist SR140333 produces long-lasting inhibition of neurogenic inflammation, but does not influence acute chemo- or thermonociception in rats
15. Neuropeptides and nociception: Recent advances and therapeutic implications
16. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P
17. Use of NK(1) knockout mice to analyze substance P-induced edema formation
18. Gabapentin antinociception in mice with acute herpetic pain induced by Herpes Simplex virus infection
19. Human mast cell tryptase: A stimulus of microvascular leakage and mast cell activation
20. Mechanisms of desensitization and resensitization of proteinase-activated receptor-2
21. Expression of trypsin in vascular endothelial cells
22. A protective role for protease-activated receptors in the airways
23. Mast cells
24. Mucosal mast cells and the allergic response against nematode parasites
25. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves
26. Mast cell heterogeneity: Effects of neuroenteric peptides on histamine release
27. Degradation of airway neuropeptides by human lung tryptase
28. Calcitonin gene-related peptide promotes mechanical nociception by potentiating the release of substance P from the spinal dorsal horn in rats
29. Calcitoninin gene-related peptide is a potent inhibitor of substance P degradation
30. Activation of silent mechanoreceptive cat C and Aδ sensory neurons and their substance P expression following peripheral inflammation
31. 1 (substance P) receptor antagonists - Why are they not analgesic in humans?
32. Release of substance P into the superficial dorsal horn following nociceptive activation of the hindpaw of the rat
33. Spinal neurokinin NK1 receptor down-regulation and antinociception: Effects of spinal NK1 receptor antisense oligonucleotides and NK1 receptor occupancy
34. Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene
35. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: Tryptase induces expression of mRNA for IL-1 β and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells
36. 5R142801 behaves as a tachykinin NK-3 receptor agonist on a spinal nociceptive reflex in the rat
37. Effect of tachykinin receptor antagonists in experimental neuropathic pain
38. Central and peripheral antialgesic action of aspirin-like drugs
39. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity
40. Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: Activation of PAR2 by PAR1-targeted ligands
41. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker
42. Impaired vasodilatory responses in the gastric microcirculation of anesthetized rats with secondary biliary cirrhosis
43. c-Fas expression in the myenteric plexus, spinal cord and brainstem following injection of formalin in the rat colonic wall